There was a house search at the Swiss pharmaceutical company Novartis. The Competition Commission (Weko) suspects the company of having misused a patent. Weko did not name the company in its announcement, but Novartis confirmed the process itself.
Novartis rejected the suspicion. "The company is confident in clarifying the legitimacy of its position and is fully cooperating with the authorities," it said.